Following on from the success of ICA-2012, BIT Congress Inc. is proud to announce that the 5th Annual International Congress of Antibodies (ICA-2013) will be held during March 18-20, 2013 in Hangzhou, China with the theme “Antibody R & D and Human Health”.
With the development and improvement of modern biotechnology in recent years, antibody engineering and technologies have become one of the main stream biomedical areas and play a pivotal role in pharmaceutical and medical industries. Initiated by BIT Life Sciences in 2008, ICA offers a unique meeting place for professionals from all over the world to share scientific information, seek research collaborations, foster new business opportunities, and discuss how to prevent and treat disease. During 4 years of successful running of ICA, it has attracted more than 1600 participants from 56 countries, and has been the most definitive antibody event in Asia.
ICA-2013 provides an ideal platform to showcase your new technologies and products in China. It is developed to maximize exposure of exhibitors, with coffee breaks and poster sessions for delegates taking place in the exhibition area.
Exposure Your New Products, Technology, Innovations and Latest Development to Visitors
Explore Business Opportunities in China and Beyond
Interaction with Visitors Face-to-Face, Exchanging Conversation and Sharing Information
Spotlight Your Technology and Its Commercial Application Promote Business
Take Advantage of the Targeted Audience at the Conference and Network in the Hall